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Abstract 
Identification of early outcomes post stroke and their predictors is important in stroke management strategies. We 
prospectively analysed 30‑day outcomes (mortality and functional ability) after stroke and their predictors among 
patients admitted within 7 days post event to a national referral hospital in Uganda. This was a prospective study of 
acute stroke patients consecutively enrolled between February and July 2014. Social demographics, clinical, labo‑
ratory, imaging characteristics, outcomes (all through 30 days), time of death were assessed using standardised 
questionnaires. Multiple regression was used to analyse the independent influence of factors on outcomes. Of 127 
patients, 88 (69.3 %) had ischemic stroke and 39 (30.7 %) had hemorrhagic stroke. Eight (6.3 %) died within 7 days, 34 
(26.8 %) died within 30 days, with 2/3 of deaths occurring in hospital. Two were lost to follow up. Of 91 survivors, 49 
(53.9 %) had satisfactory outcome, 42 (46.1 %) had poor functional outcome. At multivariate analysis, independent 
predictors of mortality at 30 days were unconsciousness (GCS <9), severe stroke at admission and elevated fast‑
ing blood sugar. None of the patients with functional independence (Barthel index ≥60) at admission died within 
30 days. Inverse independent predictors of satisfactory outcome at 30 days were older age, history of hypertension 
and severe stroke at admission. Acute stroke patients in Uganda still have high rates of early mortality and poor func‑
tional outcomes. Independent predictors of mortality and poor functional outcome were severe stroke at admission, 
unconsciousness, high fasting blood sugar, old age and history of hypertension.
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Background
Stroke is emerging as a leading cause of preventable 
death and disability worldwide (Feigin et al. 2009, 2014; 
Dalal et  al. 2008; Dalal and Bhattacharjee 2007). Many 
prospective studies based on hospital series have been 
reported (Sheikh et  al. 1983; Smith et  al. 2010; Weimar 
et  al. 2002; Jongbloed 1986; Daverat et  al. 1991; Mudzi 
et al. 2012; Heuschmann et al. 2004; Counsell and Dennis 
2001), but little is known about 30 day case fatality and 
functional outcome after stroke in developing countries 
that currently account for 85  % of global deaths from 
stroke (Feigin et  al. 2003, 2009, 2014; Dalal et  al. 2008). 
Multiple characteristics have been shown to predict early 
mortality and dependence after stroke such as age, type 
of stroke, side and site of the lesion, level of conscious-
ness, severity of neurological impairment and disability 
at baseline, medical risk factors (hypertension, diabetes), 
premorbid state, fever, blood pressure at baseline, previ-
ous stroke (Sheikh et al. 1983; Counsell and Dennis 2001; 
Greer et al. 2008; Whiteley et al. 2009; Hier and Edelstein 
1991; Kwakkel et al. 1996).
In Uganda, the only study in this area (Kwarisiima et al. 
2014) was restricted to 30 day case fatality and its predic-
tion but did not consider functional outcome at 30 days 
post stroke. Severity of neurological impairment and 
baseline functional disability which have been shown 
to predict early mortality and functional outcome post 
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stroke (Counsell and Dennis 2001) were also not assessed 
in this previous study. Identification of early outcomes 
post stroke and their predictors are important in stroke 
management strategies, especially in resource limited 
settings. The purpose of this study was to assess 30 day 
mortality and functional status after acute stroke and 




A prospective hospital-based study was conducted over 
a 6  months period between February and August 2014 
at Mulago national referral and teaching hospital. It is 
located in the capital city Kampala and has an estimated 
1500 hospital beds. The hospital’s accident and emer-
gency unit admits on average five patients per week with 
acute stroke. The hospital has no stroke unit. Stroke 
patients are admitted to the general neurology and neu-
rosurgery wards, and the general intensive care unit.
Recruitment and enrolment
During the study period, 139 patients presented to 
Mulago hospital’s accident and emergency unit with 
neurologic deficits suggestive of acute stroke that 
occurred within the previous 7 days. Stroke was defined 
according to the criteria of the World Health Organisa-
tion as sudden onset of focal and at times global neu-
rological deficits, with symptoms lasting more than 
24 h or leading to death, with no apparent cause other 
than that of vascular origin (WHO MONICA 1988). 
Brain computerised tomography (CT) confirmed stroke 
and classification of stroke subtypes was done using 
the Trial of ORG 10172 and medical disability guide-
lines for ischemic and hemorrhagic stroke respectively 
(Adams et  al. 1993; Reed group 1991). Two patients 
with suspected stroke died within a few hours of admis-
sion before a CT scan could be performed to confirm 
stroke. Of 137 patients that had non-contrast CT scan 
done, 2 patients with normal findings on both the initial 
and repeat CT scan (performed on day 7 from stroke 
onset) and 6 patients with non-stroke pathology on 
CT were excluded from the study. Of 129 patients with 
stroke confirmed on brain CT scan, 127 were recruited 
consecutively into the study upon provision of written 
informed consent to participate, while two patients with 
hemorrhagic stroke died before they and/or relatives 
could provide consent. The first choice of proxy was 
the spouse, live in companion, followed by a daughter/
son (18 years or older), parent, sibling, or close friend of 
the patient. Each patient was followed for 30 days from 
stroke onset.
Study procedures
An interviewer assessed selected social demographic 
characteristics including age, sex, tribe, district, religion, 
highest level of education, marital status, occupation, 
date of stroke onset and time to hospital presentation 
from stroke onset. We also evaluated history of pre-
existing stroke risk factors including diabetes mellitus, 
hypertension, hyperlipidemia, smoking, harmful alco-
hol consumption, heart disease, prior stroke or tran-
sient ischemic attack (TIA). A comprehensive clinical 
assessment at admission included general and cardio-
vascular examination, measurement of waist and hip 
circumferences to determine waist-hip ratio, blood pres-
sure, and neurological examination including initial level 
of consciousness using the Glasgow Coma Scale (GCS) 
(Teasdale and Jennett 1974), severity of stroke using the 
Scandinavian stroke scale (SSS) (Scandinavian Stroke 
Study Group 1985). Functional ability in activities of daily 
living was assessed using the Barthel index (BI) (Collin 
et  al. 1988). Laboratory investigations included fasting 
lipid profile [total cholesterol, low density lipoprotein 
(LDL), high density lipoprotein (HDL), and triglycerides], 
complete blood count, fasting blood sugar, erythrocyte 
sedimentation rate (ESR), rapid plasma reagin (RPR) and 
HIV test obtained after an 8 h fast.
Thirty days follow up
Study participants were transferred to the general neu-
rology unit within 24  h of arrival to the accident and 
emergency unit. On these units, they were managed by 
medical officers, internal medicine physicians, neurolo-
gists, general nurses and auxiliary staffs. The standard of 
care for acute stroke at Mulago Hospital is a modifica-
tion of the American Heart Association/American stroke 
association (AHA/ASA) guidelines (Adams et  al. 2007; 
Broderick et al. 2007). This includes supportive treatment 
to ensure a patent airway, good oxygen saturation (target 
>92 %), haemodynamic stability, temperature and glycae-
mic control, hydration, nutrition and measures to prevent 
pressure sores and deep venous thrombosis. Antihyper-
tensive drugs (labetalol and hydralazine) are used when 
blood pressure exceeds 160/100 and 180/105 mmHg for 
haemorrhagic and ischemic stroke respectively. Among 
patients with ischemic stroke, antiplatelet drugs includ-
ing aspirin and clopidogrel, and statins are administered. 
Rehabilitation includes physiotherapy, occupational, 
speech and language therapy. Patients that require 
mechanical ventilation are admitted to the general inten-
sive care unit. Recombinant tissue plasminogen activator 
is not a routine part of ‘standard of care’ in Uganda.
Each patient was followed for 30 days from stroke onset 
until either death at the hospital or discharge. Discharged 
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patients were scheduled for a neurology outpatient clinic 
review that coincided with the 30-day follow up. Prior to 
the 30 day review date, patients were called up weekly to 
assess general clinical status. Date of death was obtained 
for those that died before 30-day follow-up. The Barthel 
index assessment was done at 30-day follow-up in the 
neurology clinic. Individuals unable to come to the neu-
rology clinic had the 30-day follow-up conducted in their 
home.
Outcome measures
Thirty days mortality and functional status as measured 
by the Barthel Index were the primary outcomes of inter-
est in this study. The Barthel index reflects functional 
consequences for daily activities that are immediately 
important to a patient post stroke (Collin et  al. 1988) 
including feeding, dressing, mobility (walking on a level 
surface and ascending/descending stairs or an incline), 
and personal hygiene (bathing, grooming, toileting, and 
control of bodily functions). The Barthel Index is scored 
on a total scale of 0–39 (total functional dependence), 
40–59 (partially dependent), 60–84 (Independent) and 
85–100 (total functional independence). In this study, 
satisfactory functional outcome was defined as a score of 
≥60.
Ethical approval
The study was approved by Makerere University College 
of Health Sciences’ School of Medicine higher degrees 
research and ethics committee, Mulago national refer-
ral hospital’s research and ethics committee, and The 
Uganda National Council for Science and Technology.
Data management and statistical analysis
All statistical analyses were carried out using Stata ver-
sion 12.0 software (STATA Corporation, College Station, 
TX, USA). Univariate analysis was used to describe socio-
demographic characteristics of the study participants and 
summarize as percentages the study outcomes. Univari-
ate correlation of potential prognostic factors (baseline 
variables) and patients’ outcomes was also performed. 
The baseline variables included social demograph-
ics characteristics (age, sex, religion, level of education, 
marital status), and pre-existing risk factors for stroke 
(hypertension, diabetes mellitus, heart disease, current 
smoking, harmful alcohol consumption, prior stroke/
TIA). On examination, general assessment included 
temperature, pulse, cardiovascular status, blood pres-
sure, and abdominal obesity. Neurological assessment 
included level of consciousness using the GCS, stroke 
severity at admission using the SSS and functional sta-
tus using the BI. Laboratory parameters included white 
blood cell count, ESR, fasting blood sugar, fasting lipid 
profile, rapid plasma reagin, and HIV serology. Imaging 
procedures included non-contrast brain CT, ECG, echo-
cardiography and carotid Doppler ultrasound for patients 
that had abnormal cardiovascular examination.
At multivariate analysis by logistic regression, poten-
tial predictors from univariate analysis and the literature 
were selected. Multivariate model building using both 
forward and backward elimination was used to generate 
minimum adequate models using a 5 % significance level 
for hazard ratios for death and odds ratios for satisfactory 
outcome at 30  days after stroke. Severity of neurologi-
cal impairment at baseline and age group were retained 
as fixed terms in the model assessing for predictors of 
mortality regardless of statistical significance because of 
their known association to 30 day mortality after stroke. 
Finally, cumulative survival at 30  days post stroke, esti-
mated survival probability at 30  days from stroke onset 
according to stroke subtypes and stroke severity using 
the SSS (mild, moderate, severe) was done using the 
Kaplan–Meier curves
Results
Characteristics of the study participants
As illustrated in (Table  1), among 127 patients, 88 
(69.3  %) had ischemic stroke and 39 (30.7  %) had hem-
orrhagic stroke. Thirty-eight patients (23 ischemic 
strokes, 15 hemorrhagic strokes) presented within 24  h 
of symptom onset and out of these, 2 patients with 
ischemic stroke and 3 patients with haemorrhagic stroke 
presented within 6  h. Of 127 patients, 68 (53.5  %) were 
female. The age range was 19–99  years with median 60 
(IQR 49–75). There were similar numbers of patients 
<51 years (29.9 %) and >71 years (29.1 %). More than half 
of the patients were unemployed and had either never 
attended school or attained a primary level of education. 
Out of 127 patients, only 6 were HIV positive. Fifty-three 
patients had an abnormal cardiovascular assessment with 
atrial fibrillation on ECG in 6 patients and cardiovascular 
source of emboli on echocardiography and carotid Dop-
pler ultrasound scan in 7 patients.
Death and functional outcome at thirty days after stroke
Out of 127 patients, 2 were lost to follow up, 8 (6.3  %) 
died within 7  days and 34 (26.8  %) died within 30  days 
from stroke onset (11 out of 39 haemorrhagic strokes 
(28.2 %), 23 out of 88 ischemic strokes (26.1 %) (Fig. 1). 
Overall, in-hospital death occurred in 23 of 127 patients 
(Hemorrhagic 28.2  % and ischemic 13.6  %, P  =  0.049). 
The mean survival time was 25.7  days (SD 8.1) and the 
average length of hospital stay was 8.9  days (SD 5.8). 
At 30  days from stroke onset there were 91 survivors 
(71.7  %) and among them, 49 (53.9  %) had satisfactory 
outcome (28 totally independent and 21 independent) 
Page 4 of 10Nakibuuka et al. SpringerPlus  (2015) 4:450 
and 42 (46.1  %) had poor functional outcome (14 par-
tially dependent and 28 totally dependent).
Predictors of mortality at 30 days from stroke onset
As illustrated in (Table 2), 28 independent variables were 
tested against 30  day mortality at univariate analysis. A 
full correlation matrix is available on request. There was 
a significant difference between participants who died 
and those who survived to 30  days from stroke onset 
with respect to age ≥71 years (survivors less likely to be 
old, p = 0.023), fever (survivors less likely to have fever, 
p < 0.003), initial level of consciousness (less altered con-
sciousness in survivors, p  <  0.001), severity of stroke at 
admission (less severity in survivors, p < 0.005), disability 
at admission (less disability in survivors, p = 0.026), and 
Table 1 Characteristics of the study patients
Characteristics All participants  
n (%)





 Male 59 (46.5) 40 (45.5) 19 (48.7)
 Female 68 (53.5) 48 (54.5) 20 (51.3)
Age group (years)
 <51 38 (29.9) 28 (31.8) 10 (29.3)
 51–60 26 (20.5) 14 (15.9) 12 (30.8)
 61–70 26 (20.5) 20 (22.7) 6 (15.4)
 ≥71 37 (29.1) 26 (29.6) 11(28.2)
Median age (IQR) 60 (49–75) 62 (49–74.5) 60 (50–75)
Religion
 Catholic 42 (33.1) 29 (32.9) 13 (33.3)
 Protestant 48 (37.8) 33 (37.5) 15 (38.5)
 Islam 29 (22.8) 21 (23.9) 8 (20.5)
 Other 8 (6.3) 5 (5.7) 3 (7.7)
Highest level of education
 Never attended school 11 (8.7) 7 (7.9) 4 (10.3)
 Primary 60 (47.2) 43 (48.9) 17 (43.6)
 Secondary 38 (29.9) 26 (29.5) 12 (30.8)
 Tertiary 18 (14.2) 12 (13.6) 6 (15.4)
Marital status
 Single 8 (6.3) 5 (5.7) 3 (7.7)
 Separated or divorced 24 (18.9) 17 (19.3) 7 (17.9)
 Widowed 29 (22.8) 19 (21.6) 10 (25.6)
 Married 66 (52.0) 47 (53.4) 19 (48.7)
Employment level
 Un‑employed 69 (54.3) 48 (54.5) 21 (53.8)
 Casual employment 44 (34.7) 28 (31.8) 16 (41.0)
 Professional employment 14 (11.0) 12 (13.6) 2 (5.1)
HIV status
 Negative 121 (95.3) 85 (96.6) 36 (92.3)
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Kaplan-Meier survival estimates by stroke type
Fig. 1 Thirty day survival after stroke, by stroke subtype
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high fasting blood glucose (less elevated glucose in survi-
vors, P < 0.001).
As illustrated in (Table  3) in multivariate analysis, 
initial level of consciousness HR 4.4 (1.2–16.9), stroke 
severity at admission HR 25.5 (2.7–238) (Fig. 2) and fast-
ing blood sugar HR 3.7 (1.1–12.4) were independent 
predictors of mortality at 30 days in this series. Fever was 
significantly associated with 30 days mortality at univari-
ate analysis in this study but the sample size was small to 
allow for further analysis.
Predictors of satisfactory outcome at 30 days from stroke 
onset
Multiple potential predictors of satisfactory outcome 
were selected at univariate analysis as was done for 
30-day mortality as illustrated in (Table 2). At univariate 
analysis there was a significant difference between par-
ticipants who had satisfactory outcome and those who 
had a poor outcome at 30  days from stroke onset with 
respect to age ≥71 years (survivors less likely to be older, 
P = 0.002), marital status (survivors likely to be married, 
P  =  0.045), initial level of consciousness (less uncon-
sciousness in satisfactory outcome, p  =  0.010), stroke 
severity at admission (lower severity in satisfactory out-
come, P  <  0.0001), fasting blood sugar (less elevated 
in satisfactory outcomes, P  =  0.001), and total white 
blood cell count (less elevated in satisfactory outcome, 
P = 0.007).
As presented in (Table 4), in multivariate analysis, sat-
isfactory outcome at 30  days was inversely correlated 
with age ≥71 year OR 0.2 (95 % CI 0.04–0.7), history of 
hypertension OR 0.3 (95 % CI 0.1–0.9) and stroke sever-
ity OR 0.01 (95 % CI 0.002–0.09).
Discussion
Information of early survival and functional recovery 
after acute stroke and their prediction is important in 
stroke management strategies especially in resource lim-
ited settings.
The 30  days case fatality rate in this study was high, 
although considerably lower than the mortality rate of 
43.8 % in a study done in the same hospital 3 years prior 
(Kwarisiima et al. 2014). Our findings are comparable to 
recent studies on stroke in Africans of 27–46  % (Kwar-
isiima et al. 2014; Ogun 2004; Ogun et al. 2005; Connor 
et al. 2007a, b; Walker et al. 2011) but higher than stud-
ies in developed countries with 30  days stroke mortal-
ity rates less than 15  % (Smith et  al. 2010; Mudzi et  al. 
2012; Heuschmann et  al. 2004; Saposnik et  al. 2008; O’ 
Donnell et al. 2010). The overall in-hospital death in this 
study was comparable to studies in national hospitals in 
Africa (Ogun et al. 2005; Ojini et al. 2008) but lower than 
in-hospital stroke mortality in North America (Smith 
et  al. 2013). Thrombolysis and organized multidiscipli-
nary stroke units widely available in developed coun-
tries can reduce mortality from stroke (Feigin et al. 2009; 
Langhorne 2007; Connor et  al. 2009; Thijs et  al. 2009; 
Carter et al. 2006; Ayis et al. 2013). Better management 
of pre-stroke risk factors, particularly the use of ACE 
Table 2 Univariate correlation of  28 independent vari-
ables with  mortality or satisfactory outcome (dependent 
variables) or both
a Dichotomous variables, HIV Human Immunodeficiency Virus, ESR Erythrocyte 
Sedimentation Rate




  Marital statusa
 Physical examination and neurological assessment
  Fever (≥37.5 °C)a
  Initial level of consciousnessa
  Stroke severity at admission
  Disability at admission
 Laboratory investigations
  Fasting blood sugar
  White blood cell count
Independent variables not associated with at least one dependent vari‑




 Pre‑existing stroke risk factors
  Smokinga
  Alcohol consumptiona
  History of hypertensiona
  History of diabetes mellitusa
  History of heart diseasea
  History of stroke/transient ischemic attacka
 Physical examination and neurological assessment
  Irregular pulsea
  Blood pressure at admission (≥140/90 mmHg)a
  Abnormal cardiovascular examinationa
  Abdominal obesitya
 Laboratory investigations
  Total cholesterol
  Low density lipoprotein cholesterol
  High density lipoprotein cholesterol
  Triglycerides
  Rapid plasma reagina
  HIVa
  ESRa
  Imaging investigations (CT scan)
  Stroke subtypea
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inhibitors (Selim et  al. 2005; Álvarez-Sabín et  al. 2007), 
aspirin (Wilterdink et al. 2001; Ovbiagele et al. 2008) and 
the wider use of pre-stroke statins (Yoon et al. 2004) may 
prevent catastrophic stroke that is common in the Afri-
can setting (Feigin et  al. 2009). In addition, most of the 
studies in developed countries are community based. In 
Africa on the other hand, the high case fatality has been 
blamed on limited health care access, delayed presenta-
tion to hospital, and a shortage of adequately trained 
professionals to provide acute care and rehabilitation of 
stroke patients (Owolabi et  al. 2007) as well as lack of 
stroke units. Similar factors may be responsible for the 
poor functional outcome among the survivors seen in 
this study. The early recovery in activities of daily liv-
ing among stroke survivors in developed countries is 
generally more favorable (Wade and Hewer 1987) than 
our findings. This study dealt with patients admitted to 
a national referral hospital. Hospital data on stroke are 
usually biased towards the more serious or complicated 
cases (Bamford et  al. 1986). It is possible that only the 
most severe stroke cases end up presenting to hospi-
tal, and that this cohort is not likely to be entirely rep-
resentative of all strokes in the community, given that a 
large number of stroke patients per year is expected in a 
Table 3 Predictors of mortality at 30 days after acute stroke
Variable Dead n/N (%) Unadjusted HR  
95 % CI




 Male 13/59 (22.0) 1
 Female 21/68 (30.9) 1.6 (0.7–3.6) 0.263
Age group (years)
 <51 7/38 (18.4) 1 1
 51–60 4/26 (15.4) 0.8 (0.2–3.1) 0.752 1.4 (0.2–7.7) 0.713
 61–70 7/26 (26.9) 1.6 (0.5–5.4) 0.421 1.4 (0.3–6.3) 0.660
 ≥71 16/37 (43.2) 3.4 (1.2–9.6) 0.023 3.8 (0.9–15.7) 0.069
History of stroke/TIA
 No 7/35 (20.0) 1
 Yes 27/90 (30.0) 1.7 (0.7–4.4) 0.263
 Don’t know 0/2 (0) N/A
History of hypertension
 No 13/49 (26.5) 1
 Yes 21/78 (26.9) 1.02 (0.5–2.2) 0.961
Febrile (≥37.5 °C)
 No 27/118 (22.9) 1
 Yes 7/9 (77.8) 11.8 (2.3–60.1) 0.003
Hypertension (≥140/90 mmHg)
 No 11/30 (36.7) 1 1
 Yes 23/97 (23.7) 0.5 (0.2–1.3) 0.165 0.4 (0.1–1.3) 0.135
Initial level of consciousness
 GCS ≥9 21/104 (20.2) 1 1
 GCS <9 13/23 (56.5) 5.1 (1.9–13.3) 0.001 4.4 (1.2–16.9) 0.029
Stroke severity at admission
 Mild–Moderate (30–58) 1/45 (2.2) 1 1
 Severe (15–29) 13/43 (30.2) 19.1 (2.4–153.6) 0.006 15.3 (1.7–136) 0.014
 Very severe (0–14) 20/39 (51.3) 46.3 (5.8–370.4) <0.0001 25.5 (2.7–238) 0.004
Fasting blood sugar
 Normal 9/65 (13.9) 1 1
 IGT 8/26 (30.8) 2.7 (0.9–8.2) 0.067 2.2 (0.6–8.1) 0.249
 High 17/36 (47.2) 5.6 (2.1–14.6) <0.0001 3.7 (1.1–12.4) 0.031
Stroke subtype
 Ischemic 23/88 (26.1) 1 1
 Hemorrhagic 11/39 (28.2) 0.9 (0.4–2.0) 0.808 1.8 (0.6–5.7) 0.294
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hospital with over 1500 beds serving Kampala’s 1.6 mil-
lion people, as well as an additional estimated 1.5 mil-
lion from neighbouring districts and beyond. Also, only 
participants with onset of stroke symptoms within 7 days 
were recruited. While our study does not permit a causal 
inference regarding the relatively high mortality out-
comes, it is likely that care access issues in line with lim-
ited health budgets in most of sub-Saharan Africa play a 
substantial role.
A positive aspect of our study findings is that compared 
with Kwarisiima study at the same hospital done sev-
eral years prior, stroke outcomes appear to be somewhat 
improved (Kwarisiima et  al. 2014) although this com-
parison can hardly be made in rational terms. In Kwar-
isiima study 30 % of the stroke patients were unconscious 
and hence more severe strokes compared to 18 % in our 
study, which might account for the apparent improve-
ment. There have been recent improvements in resources 
available at the national referral hospital in Ugandan, 
including the addition of neurology specialists to the 
work force, visiting international neurology specialists 
to help train students and staff, availability of additional 
resource for CT scanning, and a 50 % increase in number 
of mechanical ventilator support devices. In addition, a 
trauma center with dedicated staff was opened up to deal 
with severely injured trauma patients that form the bulk 
of emergencies at the accident and emergency unit at the 
hospital. This ensured that non-trauma emergencies pre-
senting to the non-trauma resuscitation room were much 
better attended to. Finally, a standardised triage tool was 
introduced at the accident and emergency unit and staff 
trained in emergency triage could more readily refer indi-
viduals with suspected stroke to a care setting that could 
potentially minimize stroke-related complications such 
as respiratory compromise or infection. Never the less, it 
is more likely that differences in case mix between 2010 
and 2014 can explain statistically the differences in mor-
tality, without underestimating the role of the improve-
ments in stroke care.
With respect to risk factors for mortality, unconscious-
ness, severe stroke at admission, high fasting blood sugar 
are known to be predictors of early mortality after acute 
stroke (Counsell and Dennis 2001; Veerbeek et al. 2011) 
and these were independent predictors of 30 day mortal-
ity in this study. Hospital data on stroke are usually biased 
towards the more serious or complicated cases (Bamford 
et al. 1986) and this study dealt with patients admitted to 
a national referral hospital. Unconsciousness and severe 
stroke as independent predictors of early mortality were 
directly related to the severity of the neurological dam-
age (Sheikh et  al. 1983; Heuschmann et  al. 2004). None 
of the patients with independent scores (BI >60) on the 
disability scale at baseline died at 30 days from stroke in 
this study in agreement with studies that found greater 
disability on admission to be associated with worse sur-
vival (Hier and Edelstein 1991). Fasting blood sugar as an 
independent predictor of 30 days mortality was in disa-
greement with some studies (Cztonkowska et  al. 1997). 
Severe acute stroke has been associated with reactive 
hyperglycemia even in patients without a history of dia-
betes due to a major stress response which accounts for 
the worse prognosis of these patients (Gray et al. 2004). 
Impaired glucose metabolism, with prevalence of previ-
ously unrecognized diabetes mellitus or impaired glu-
cose tolerance preceding stroke is also responsible for 
hyperglycemia after stroke (Gray et al. 2004). Risk factor 
screening of the general populations in limited resource 
settings is low.
Multivariate analysis in this study showed that satis-
factory outcome was inversely associated with old age, 
history of hypertension, and severity of stroke at admis-
sion. Severity of stroke at admission was in agreement 
with multiple studies in a systematic review (Counsell 
and Dennis 2001), as well as increasing age as a predic-
tor of unsatisfactory outcome (Hier and Edelstein 1991; 
Kwakkel et  al. 1996). However, older age appeared pro-
tective for longer term survival while vascular risk factors 
such as hypertension appeared to have little effect (Coun-
sell and Dennis 2001). It is possible that risk factors for 
stroke survival in Africa may differ from other settings. 
For example, older individuals may be less likely to have 
an extended support system of adult care givers than 
their younger counter parts. Perhaps in a setting where 
formal healthcare is scarce, family support may be more 
the norm and have a protective effect in stroke recov-
ery. More information is needed, especially concerning 




















Kaplan-Meier survival estimates by stroke severity
Fig. 2 Thirty day survival after stroke, by degree of stroke severity at 
admission
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Table 4 Predictors of satisfactory outcome at 30 days after acute stroke in 127 patients








 Male 28/59 (47.5) 1
 Female 21/68 (30.9) 0.5 (0.2–1.02) 0.057
Age group (years)
 <51 21/38 (55.3) 1 1
 51–60 12/26 (46.2) 0.7 (0.2–1.9) 0.475 0.4 (0.1–1.8) 0.244
 61–70 9/26 (34.6) 0.4 (0.4–1.2) 0.107 0.6 (0.1–2.4) 0.434
 ≥71 7/37 (18.9) 0.2 (0.1–0.5) 0.002 0.2 (0.04–0.7) 0.015
Education
 None and primary 24/71 (33.8) 1
 Secondary and tertiary 25/56 (44.6) 1.6 (0.8–3.2) 0.214
Marital status
 Not married 18/61 (29.5) 1
 Married 31/66 (46.9) 2.1 (1.01–4.4) 0.045
History of stroke/TIA
 No 15/35 (42.9) 1
 Yes 33/90 (36.7) 0.8 (0.3–1.7) 0.523
 Don’t know 1/2 (50.0) 1.3 (0.1–23.1) 0.843
History of hypertension
 No 24/49 (48.9) 1 1
 Yes 25/78 (32.1) 0.5 (0.2–1.02) 0.058 0.3 (0.1–0.9) 0.033
Febrile
 No 47/118 (39.8) 1
 Yes 2/9 (22.2) 0.4 (0.1–2.2) 0.308
Hypertension (>140/90 mmHg)
 No 11/30 (36.7) 1
 Yes 38/97 (39.2) 1.1 (0.5–2.6) 0.805
Initial level of consciousness
 GCS ≥9 46/104 (44.2) 1 1
 GCS <9 3/23 (13.0) 0.2 (0.1–0.7) 0.010 0.3 (0.04–2.3) 0.261
Stroke severity at admission
 Mild and moderate 35/45 (77.8) 1 1
 Severe 12/43 (27.9) 0.1 (0.04–0.3) <0.0001 0.06 (0.02–0.2) <0.0001
 Very severe 2/39 (5.1) 0.02 (0.003–0.07) <0.0001 0.01 (0.002–0.09) <0.0001
Fasting blood sugar
 Normal 33/65 (50.8) 1
 Impaired glucose tolerance 10/26 (38.5) 0.6 (0.2–1.5) 0.290
 High 6/36 (16.7) 0.2 (0.1–0.5) 0.001
White blood cell count
 Low 9/13 1
 Normal 37/97 0.1 (0.1–0.9) 0.042
 High 3/17 0.1 (0.01–0.5) 0.007
Stroke subtype
 Hemorrhagic 13/39 (33.3) 1 1
 Ischemic 36/88 (40.9) 1.4 (0.6–3.1) 0.419 0.4 (0.1–1.5) 0.169
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in addition to many other predictor variables (Counsell 
and Dennis 2001; Hier and Edelstein 1991; Kwakkel et al. 
1996).
There are limitations of our study. The sample size was 
small hampering the analysis of some prognostic indica-
tors. It is hospital-based and not likely to be entirely rep-
resentative of strokes occurring in the community. Also 
the cohort was restricted by the inclusion of only acute 
stroke patients with symptom onset within a week. How-
ever, the study provides a preliminary database on early 
mortality and functional outcome which can inform 
stroke management strategies.
Conclusions
Early death, relatively high in-hospital mortality, and 
poor functional outcome are common in Ugandans who 
experience acute stroke. However, compared to a pre-
vious study conducted in the same setting, stroke out-
comes may be improving. Factors associated with death 
and functional outcome were largely non modifiable.
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